Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

29%

7 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (9)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (5)

Trial Status

Completed15
Unknown3
Terminated3
Recruiting2
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07527572Phase 2Not Yet RecruitingPrimary

Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

NCT07199998Recruiting

Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

NCT00153517Phase 2CompletedPrimary

Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy

NCT03500107Not ApplicableRecruitingPrimary

Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial

NCT02392026Phase 4CompletedPrimary

Safety and Tolerability of Metronidazole Gel 1.3%

NCT03943823Phase 4Terminated

Postmenopausal Pessary Users: Estrogen Versus Trimosan

NCT05649735Not ApplicableCompletedPrimary

EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS

NCT01322971Not ApplicableTerminatedPrimary

Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population

NCT04989543Not ApplicableCompletedPrimary

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)

NCT04171947Not ApplicableCompletedPrimary

Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment

NCT02860845Phase 4Completed

Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections

NCT02272231CompletedPrimary

Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women

NCT03134924Not ApplicableCompletedPrimary

Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention "WASH-2"

NCT02641717Not ApplicableCompleted

Validity of Patient-Collected Wet Mounts

NCT02558179UnknownPrimary

Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method

NCT02314429Phase 1CompletedPrimary

Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis

NCT02687789Not ApplicableCompletedPrimary

Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis

NCT01293643Phase 3CompletedPrimary

A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)

NCT00484653Not ApplicableCompletedPrimary

Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman

NCT02139839Early Phase 1CompletedPrimary

Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14

Scroll to load more

Research Network

Activity Timeline